Pterostilbene.
A blueberry stilbene closely related to resveratrol, used for antioxidant and metabolic support. Two methyl groups let it stay in the blood far longer.
Reviewed March 2026
- Category
- Compound
What Pterostilbene is, and what it does.
- Does it work
- Suits people already building a longevity or NAD routine who want a stilbene that survives first-pass metabolism better. Human outcome trials are few.
- How much to take
- Start with 50mg to 100mg a day, with a meal that contains some fat. That band is where daily use sits.
- Time to feel it
- Blood lipid and antioxidant markers were read at six to eight weeks in the human work. This is a panel change, not a sensation.
- The first dose
- Plasma levels rise within hours and stay up longer than resveratrol would. Nothing about the day itself changes on the first dose.
- With regular use
- Weeks of daily use are where the marker changes were measured in trials, chiefly lipid and oxidative stress panels rather than anything you notice.
- How well tolerated
- Well tolerated at the amounts studied. Higher trial doses have been linked to lipid changes, so check with your doctor if you take a lipid medication.
- How it feels
- Nothing subjective, which is expected for a polyphenol. What it contributes is measured on blood work over weeks.
- The overlooked benefit
- Capping two of the three hydroxyls removes two conjugation sites, which is the whole reason it lasts longer in plasma than resveratrol at the same milligram.
150 to 500mg a day is where Pterostilbene works.
Source: Timmers 2011 + Bhatt 2012 metabolic studies
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Pterostilbene has emerging evidence. Based on 3906+ studies.
- blood lipids already in the normal rangeRandomised trial
- markers of oxidative stressRandomised trial
- longer plasma half-life than resveratrolAnimal study
- Nrf2-driven antioxidant enzyme expressionIn vitro study
- AMPK and sirtuin signallingAnimal study
Questions people ask about Pterostilbene.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Stilbenes are cleared very fast by sulfotransferases and UGTs, and quercetin competes for those same conjugating enzymes. Co-ingestion slows stilbene conjugation and raises how much stays unconjugated.
Piperine inhibits intestinal and hepatic glucuronidation, the main route that clears resveratrol. Adding it raises stilbene exposure from the same dose.
Standardised piperine slows UGT-mediated conjugation of stilbenes in the gut wall and liver. The result is a higher and longer plasma curve from an unchanged dose.
Sirtuins consume NAD as a co-substrate every time they deacetylate, and stilbenes act through that sirtuin axis. An NAD precursor keeps the pool the enzyme draws on topped up.
NMN feeds the NAD pool that sirtuin activity depletes. Pairing it with a stilbene supplies the co-substrate rather than only the signal.
Sirtuin deacetylation cannot proceed without NAD, so NAD availability caps what stilbene activation can express. The pairing is mechanistically clean even where the oral route is still argued.
Fisetin and the stilbenes are both polyphenols cleared by the same sulfotransferases and UGTs, so they compete for clearance. They are routinely formulated together for that overlapping profile.
Curcumin is also heavily glucuronidated and sulfated on first pass, so it competes with stilbenes for the same conjugating capacity. Formulators pair them and often add a UGT inhibitor for the same reason.
EGCG and stilbenes are both polyphenols handled by COMT, sulfotransferases and UGTs. Taken together they compete for that conjugating capacity.
Resveratrol dampens platelet aggregation through eicosanoid and thromboxane routes, and EPA does the same by shifting eicosanoid substrate. Stacking them adds two dampening inputs to one normal clotting process.
Ginkgolides antagonise platelet activating factor while stilbenes act on thromboxane-linked aggregation. The two effects are additive on the same normal clotting step.
Nattokinase acts on fibrin while stilbenes act on platelet aggregation. Combining them stacks two separate inputs on normal clot formation.
Garlic thiosulfinates reduce platelet aggregation in their own right. Layered with a stilbene the two act on the same normal process from different chemistry.
At higher intakes alpha-tocopherol reduces platelet adhesion and aggregation. Combined with a stilbene the two contribute to the same normal clotting endpoint.
Pterostilbene is the 3,5-dimethyl ether of resveratrol, so the two share a stilbene backbone and much of the same signalling literature. The methyl groups block two of the sites where resveratrol is conjugated, which is why pterostilbene persists longer after an equivalent oral dose. Formulations carry both to cover the fast-clearing and slow-clearing ends of the same chemistry, and comparative work in animals has run the two side by side.
The two methoxy groups make pterostilbene markedly more lipophilic than resveratrol and correspondingly less water soluble. A medium-chain triglyceride vehicle supports micellar solubilisation without heavy bile demand. This is physicochemical reasoning that applies to the whole class.
Phospholipid dispersion keeps the crystalline stilbene wetted through gastric transit instead of letting it clump. It is the standard route for softgel and liquid formats. The argument is formulation physics; a blood-level claim would need that product's own data.
Complexing a lipophilic polyphenol with phosphatidylcholine raises apparent solubility and slows re-crystallisation in the gut. The same approach is used across the polyphenol category. Carrier weight is the practical cost of the approach.
Pterostilbene retains a free 4-hydroxyl that can donate a hydrogen atom, leaving a phenoxyl radical that aqueous ascorbate reduces back to the parent phenol. That recycling is why phenolic antioxidants are formulated alongside ascorbate. Settled redox chemistry rather than an outcome claim.
Dihydrolipoate restores the ascorbate and glutathione pools that in turn regenerate oxidised stilbenes. It sits a level above pterostilbene in the same network. No combination study is needed to state the biochemistry, and none exists for the pair.
Glutathione synthesis is limited by cysteine availability, and glutathione handles conjugation of oxidised stilbene metabolites. Supplying cysteine supports that capacity rather than adding an independent effect. Established pathway biochemistry.
Glutathione appears alongside pterostilbene throughout the antioxidant literature because it is both a partner and a consumable in the same chemistry. Oxidised stilbene quinones are conjugated by it before excretion. Stating the two-way relationship is more accurate than calling it purely additive.
Ubiquinol works inside the lipid bilayer regenerating tocopherol, a compartment a stilbene only partly reaches even at its higher lipophilicity. Both are described in the mitochondrial literature but at different points. Coverage rather than duplication is the argument.
Astaxanthin spans the lipid bilayer with polar groups at both ends, sitting where neither a stilbene nor a tocopherol sits. Combining them covers separate positions in the membrane. This is formulation reasoning from known chemistry, not a tested pair.
Tocotrienols move through membranes more freely than tocopherols because of their unsaturated tail, covering the lipid phase while the stilbene works nearer the surface. The pairing splits compartments. Mechanistic grounding without combination data.
Glutathione peroxidase is a selenoenzyme and cannot function without selenocysteine at its active site. That enzyme is the workhorse of peroxide handling that stilbene antioxidant chemistry runs alongside. Textbook cofactor biochemistry, no citation required.
Pterostilbene binds iron, an activity documented directly in in vitro antimicrobial work where iron chelation was identified as part of its mechanism. In a supplement context the same chemistry lowers free non-heme iron at the absorptive surface. Spacing a mineral dose from a polyphenol dose is the practical consequence.
The remaining free hydroxyl on pterostilbene can coordinate divalent minerals in the gut lumen, though the two methylated positions reduce the binding capacity relative to resveratrol. The effect is smaller but not absent. Read it as a timing consideration in mineral-containing formulations.
Both compounds are cleared largely by UGT-mediated glucuronidation of their free hydroxyl groups. Co-dosing can shift the free fraction of either in a direction that has not been measured for this pair. Mechanistic caution only.
Berberine raises the AMP to ATP ratio and activates AMPK, while dietary pterostilbene has been reported to shift lipid metabolism and antioxidant enzyme expression in animals. The two converge on energy-sensing signalling from different directions. The evidence for the convergence is preclinical and no human combination trial exists.
Urolithin A is studied for mitophagy signalling and stilbenes for biogenesis signalling, which are the removal and replacement halves of mitochondrial turnover. Longevity-positioned formulas pair them on that logic. It is mechanistic framing rather than a demonstrated joint result in people.
Spermidine induces autophagy through acetyltransferase inhibition, a route independent of the sirtuin and AMPK signalling described for stilbenes. Both appear in the same longevity formulation category. The pairing rests on preclinical mechanism and not on human combination evidence.
Taurine is required for mitochondrial tRNA modification that supports respiratory chain protein synthesis, a distinct step from stilbene signalling. The pairing adds coverage rather than reinforcement. Mechanistic reasoning, untested as a combination.
A lower gastric pH improves wetting and dispersion of some poorly soluble crystalline actives before they reach the small intestine. Acidifying agents are used in formulation for that reason. The rationale is general and has not been measured for this compound specifically.
Grape and berry material supplies both stilbenes and proanthocyanidins that are broken down by the same colonic bacteria into overlapping phenolic acids. Pairing a purified stilbene with a whole extract raises total substrate for that route. Any joint effect beyond shared handling has not been measured.
Nothing specific on file for Pterostilbene. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Pterostilbene actually does.
Pterostilbene is 3,5-dimethoxy-4-hydroxystilbene, the dimethyl ether of resveratrol, and occurs naturally in blueberries and in heartwood of several Pterocarpus species.
Methylating two of the three phenolic hydroxyls removes two of the sites that carry glucuronidation and sulfation, which is the structural reason pterostilbene has a longer plasma half-life than resveratrol after an equivalent oral dose.
The same methylation raises lipophilicity substantially, improving passive membrane crossing while lowering aqueous solubility, so formulation has to address dispersion rather than permeability.
One free hydroxyl remains at the 4 position, and that group is what supports hydrogen atom donation to radicals and coordination of transition metals.
Where Pterostilbene comes from.
Although pterostilbene occurs in blueberries, there is far too little there to make a supplement from, so what you buy is built in a reactor. Two aromatic pieces are joined to make the stilbene shape, then two positions are capped with methyl groups, which is exactly what makes this molecule different from resveratrol and what makes it last longer in the body. The crystals are purified, tested for how much is the trans form, milled and encapsulated, and kept out of the light because light changes the shape.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Commercial production begins from simple substituted benzaldehyde and phenylacetic-type precursors rather than from plant material, because blueberry and heartwood concentrations are too low for economic recovery
A coupling reaction joins the two aromatic rings across an ethylene bridge and sets the trans geometry that defines the active isomer
The two meta hydroxyls are converted to methoxy groups, which is the structural feature that distinguishes pterostilbene from resveratrol and blocks two conjugation sites
Crude product is recrystallised from solvent and dried under vacuum to bring residual solvents within specification
Material is assayed for total purity and for trans isomer content, since light exposure converts a share of trans to cis
The dried crystals are milled, optionally to a micronised distribution, blended with flow agents and filled into capsules, or dispersed into a phospholipid carrier for softgels; light-protective packaging is used throughout
Getting Pterostilbene from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Pooling trials of red wine polyphenols, the family that includes resveratrol and its relatives, found effects on blood vessel function that were small and inconsistent between studies.Meta-analysis. Weaver et al., 2021 (European journal of nutrition). PMID 32303823 ↗
- In a randomised placebo-controlled design testing nicotinamide riboside with pterostilbene during an experimental muscle injury protocol, the authors reported no improvement in the measured recovery outcomes over placebo; a failure to detect a difference, not evidence that none exists.Randomised trial. Jensen et al., 2022 (JCI Insight). PMID 35998039 ↗
- Dietary pterostilbene shifted lipid metabolism markers and antioxidant enzyme measures in the animals studied; markers in an animal model rather than human outcomes.Animal study. Zhang et al., 2024 (Journal of Animal Physiology and Animal Nutrition). PMID 38372476 ↗
- Maternal pterostilbene supplementation altered milk composition and offspring gut antioxidant and lipid metabolism measures in an animal model.Animal study. Bai et al., 2026 (Antioxidants). PMID 42193154 ↗
- Chronic pterostilbene feeding was associated with browning markers in adipose tissue of mice on a high-fat diet; a tissue marker in a rodent model.Animal study. La Spina et al., 2019 (International Journal of Molecular Sciences). PMID 31671737 ↗
- Dietary pterostilbene was reported to reduce intestinal damage and immunological stress markers in challenged broiler chickens.Animal study. Zhang et al., 2020 (Journal of Animal Science). PMID 31822918 ↗
- A head to head dietary comparison of resveratrol and pterostilbene reported differences in muscle antioxidant capacity measures between the two stilbenes in the animals studied.Animal study. Huang et al., 2026 (Meat Science). PMID 42008881 ↗
- Pterostilbene chelated iron and disrupted bacterial membranes in culture, which grounds its metal-binding chemistry; a laboratory finding in bacterial isolates with no bearing on human supplementation.In vitro study. Yang et al., 2026 (The Veterinary Journal). PMID 42162898 ↗
- A multi-ingredient supplement naming pterostilbene among its components was associated with slower age-dependent mobility decline and gene expression changes in a nematode model; the effect cannot be attributed to any single component.Animal study. Yanyatan et al., 2026 (Biogerontology). PMID 42365207 ↗
These are the studies our verdict leans on, chosen from the 916 we read for Pterostilbene. The full linked list is below.
The studies, linked.
12 sources behind our Pterostilbene verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialEffect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative StressClinicalTrials.gov ↗PHASE2 · 80 participants · Completed
- Clinical trialA Phase II, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Efficacy of BASIS™ (Nicotinamide Riboside and Pterostilbene) Treatment for Kidney Protection in Patients Treated by Complex Aortic Aneurysm Repair and Aortic Arch ReconstructionClinicalTrials.gov ↗PHASE2 · 54 participants · Completed
- Clinical trialEffects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopauseClinicalTrials.gov ↗NA · 40 participants · Completed
- Clinical trialEffect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans - A Randomized, Placebo-controlled, Clinical TrialClinicalTrials.gov ↗NA · 32 participants · Completed
- Clinical trialRandomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics, Pharmacodynamics & Safety of Escalating Doses of Basis (Nicotinamide Riboside and Pterostilbene) in Patients With Acute Kidney Injury (AKI)ClinicalTrials.gov ↗NA · 24 participants · Completed
- Clinical trialEvaluation of the Oral Bioavailability of a New Formulation of Pterostilbene Co-crystal in Comparison With Its Free Form in Healthy Volunteers: Crossover, Randomized and Simple Blind Study (BIOPTERO2)ClinicalTrials.gov ↗NA · 6 participants · Completed
- Clinical trialEvaluation of the Oral Bioavailability of Pterostilbene Cocrystal Compared to Its Free Form in Healthy Volunteers. Crossover, Randomized, Double-Blind Study (BIOPTERO)ClinicalTrials.gov ↗NA · 6 participants · Completed
- Clinical trialA Randomized Placebo-controlled Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS StudyClinicalTrials.gov ↗NA · 380 participants · Active not recruiting
- Clinical trialA Randomized Placebo-controlled Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Study. Extension ProtocolClinicalTrials.gov ↗NA · 300 participants · Recruiting
- Clinical trialA Phase II, Single-center, Randomized Double Blind, Placebo Controlled Study to Evaluate the Effect of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Ambulant Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov ↗PHASE1 · 90 participants · Recruiting
- Clinical trialBasis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma PatientsClinicalTrials.gov ↗PHASE1 · 48 participants · Unknown
- Clinical trialOpen-Label Randomized Phase II Trial of Megestrol Acetate With or Without Pterostilbene in Patients With Endometrial Cancer Scheduled for HysterectomyClinicalTrials.gov ↗PHASE2 · 44 participants · Active not recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.


